Moderna, Inc. (MRNA)
NASDAQ$34.62
Market Cap
$13.36B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
61 of 924
Rank in Industry
43 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
MRNA Insider Trading Activity
MRNA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $6,008,569 | 2 | 4 |
Sells | $76,825,399 | 54 | 96 |
Related Transactions
| Bancel Stephane | Chief Executive Officer | 1 | $5M | 0 | $0 | $5M |
| SAGAN PAUL | director | 1 | $1M | 0 | $0 | $1M |
| Mock James M | Chief Financial Officer | 0 | $0 | 9 | $603,556 | $-603,556 |
| Klinger Shannon Thyme | Chief Legal Officer | 0 | $0 | 11 | $1.28M | $-1.28M |
| Hoge Stephen | President | 0 | $0 | 14 | $9.16M | $-9.16M |
| AFEYAN NOUBAR | director | 0 | $0 | 20 | $65.78M | $-65.78M |
About Moderna, Inc.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus …
Insider Activity of Moderna, Inc.
Over the last 12 months, insiders at Moderna, Inc. have bought $6.01M and sold $76.83M worth of Moderna, Inc. stock.
On average, over the past 5 years, insiders at Moderna, Inc. have bought $6.01M and sold $720.68M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Bancel Stephane (Chief Executive Officer) — $5M. SAGAN PAUL (director) — $1M.
The last purchase of 31,620 shares for transaction amount of $1M was made by SAGAN PAUL (director) on 2025‑03‑03.
List of Insider Buy and Sell Transactions, Moderna, Inc.
| 2025-03-03 | Bancel Stephane | Chief Executive Officer | 160,314 0.0429% | $31.22 | $5M | +14.37% | ||
| 2025-03-03 | SAGAN PAUL | director | 31,620 0.0086% | $31.76 | $1M | +14.37% | ||
| 2024-12-09 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 529 0.0001% | $44.68 | $23,637 | -21.30% | |
| 2024-12-03 | Sale | Hoge Stephen | President | 314 <0.0001% | $43.30 | $13,595 | -14.28% | |
| 2024-12-03 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 112 <0.0001% | $43.30 | $4,849 | -14.28% | |
| 2024-11-29 | Sale | Hoge Stephen | President | 291 <0.0001% | $42.79 | $12,452 | -13.02% | |
| 2024-11-29 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 1,418 0.0004% | $42.79 | $60,675 | -13.02% | |
| 2024-11-29 | Sale | Mock James M | Chief Financial Officer | 1,420 0.0004% | $42.79 | $60,761 | -13.02% | |
| 2024-11-11 | Sale | Hoge Stephen | President | 277 <0.0001% | $46.10 | $12,771 | -7.88% | |
| 2024-10-07 | Sale | Mock James M | Chief Financial Officer | 715 0.0003% | $60.12 | $42,986 | -30.05% | |
| 2024-09-09 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 551 0.0002% | $73.57 | $40,539 | -45.05% | |
| 2024-09-03 | Sale | Hoge Stephen | President | 318 0.0001% | $76.99 | $24,483 | -42.12% | |
| 2024-09-03 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 114 <0.0001% | $76.99 | $8,777 | -42.12% | |
| 2024-08-29 | Sale | Hoge Stephen | President | 300 0.0001% | $78.03 | $23,408 | -45.46% | |
| 2024-08-29 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 162 <0.0001% | $78.03 | $12,640 | -45.46% | |
| 2024-08-29 | Sale | Mock James M | Chief Financial Officer | 162 <0.0001% | $78.03 | $12,640 | -45.46% | |
| 2024-08-28 | Sale | Klinger Shannon Thyme | Chief Legal Officer | 1,319 0.0006% | $79.39 | $104,722 | -45.90% | |
| 2024-08-28 | Sale | Mock James M | Chief Financial Officer | 1,321 0.0006% | $79.39 | $104,881 | -45.90% | |
| 2024-08-12 | Sale | Hoge Stephen | President | 254 0.0001% | $84.10 | $21,363 | -47.18% | |
| 2024-07-31 | Sale | AFEYAN NOUBAR | director | 15,000 0.0109% | $119.96 | $1.8M | -63.54% |
Total: 1062
*Gray background shows transactions not older than one year
Insider Historical Profitability
262.16%
| Bancel Stephane | Chief Executive Officer | 9210686 2.3873% | $318.87M | 1 | 416 | |
| SAGAN PAUL | director | 312027 0.0809% | $10.8M | 2 | 1 | +262.16% |
| Trieu Vuong | Chairman of the Board | 11117141 2.8815% | $384.88M | 2 | 0 | |
| Ramelli Joseph W. | Chief Executive Officer | 440653 0.1142% | $15.26M | 4 | 0 | |
| FRENCH J MICHAEL | CEO | 10000 0.0026% | $346,200.00 | 1 | 0 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$961,890,236 | 276 | 22.46% | $13.13B | |
$211,610,344 | 91 | 38.45% | $7.69B | |
$2,765,836 | 72 | 20.00% | $13.25B | |
$108,876,545 | 67 | 72.81% | $7.67B | |
$2,449,191,716 | 58 | 16.50% | $71.69B |
MRNA Institutional Investors: Active Positions
| Increased Positions | 374 | +37.78% | 37M | +14.25% |
| Decreased Positions | 434 | -43.84% | 22M | -8.24% |
| New Positions | 140 | New | 9M | New |
| Sold Out Positions | 176 | Sold Out | 7M | Sold Out |
| Total Postitions | 930 | -6.06% | 277M | +6.01% |
MRNA Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $1.25M | 10.45% | 40.32M | +97,536 | +0.24% | 2024-12-31 |
| Baillie Gifford & Co | $1.2M | 10.07% | 38.89M | -4M | -8.4% | 2024-12-31 |
| Blackrock, Inc. | $798,519.00 | 6.68% | 25.79M | +759,934 | +3.04% | 2024-12-31 |
| Fmr Llc | $577,857.00 | 4.84% | 18.66M | +1M | +7.38% | 2024-12-31 |
| State Street Corp | $544,191.00 | 4.55% | 17.58M | +730,024 | +4.33% | 2024-12-31 |
| Theleme Partners Llp | $226,220.00 | 1.89% | 7.31M | +80,000 | +1.11% | 2024-12-31 |
| Geode Capital Management, Llc | $224,192.00 | 1.88% | 7.24M | +171,774 | +2.43% | 2024-12-31 |
| Ubs Group Ag | $157,072.00 | 1.31% | 5.07M | +3M | +123.58% | 2024-12-31 |
| Invesco Ltd. | $155,000.00 | 1.3% | 5.01M | +979,858 | +24.34% | 2024-12-31 |
| Flagship Pioneering Inc. | $143,411.00 | 1.2% | 4.63M | 0 | 0% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.